FEBS Letters · 2006 · 316 citations · 17 references
Life SciencesNeurobiologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceProtein-protein InteractionsBotulinum Toxin TherapyNeurotransmissionNeurotransmitter ReceptorsNeurotransmitter ReleaseSynaptic TransmissionSynaptic Vesicle ReleaseBotulinum NeurotoxinBotulinum ToxinsFusion Machinery StructureSynaptic Vesicle TransportSynaptotagmin-mediated ReleaseTransmembrane DomainsTransmembrane ProteinsVesicle Fusion Machinery
Botulinum neurotoxins (BoNTs) inhibit neurotransmitter release by selectively cleaving core components of the vesicular fusion machinery. The synaptic vesicle proteins Synaptotagmin-I and -II act as receptors for BoNT/B and BoNT/G. Here we show that BoNT/A also interacts with a synaptic vesicle protein, the synaptic vesicle glycoprotein 2C (SV2C), but not with the homologous proteins SV2A and SV2B. Binding of BoNT/A occurs at the membrane juxtaposed region preceding transmembrane domain 8. A peptide comprising the intravesicular domain between transmembrane domains 7 and 8 specifically reduces the neurotoxicity of BoNT/A at phrenic nerve preparations demonstrating the physiological relevance of this interaction.
17
SV2A and SV2B Function as Redundant Ca2+ Regulators in Neurotransmitter Release
Roger Janz, Yukiko Goda, Martin Geppert et al. · Neuron · 1999 · 368 citations · Full text
Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells
Min Dong, David A. Richards, Michael C. Goodnough et al. · The Journal of Cell Biology · 2003 · 294 citations · Full text